LC
CORZ

Lindbrook Capital’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Lindbrook Capital’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-182,369
Closed -$13.7K – 2980
2022
Q4 		$13.7K Buy
+182,369
New +$83.6K ﹤0.01% 1273

Other funds holding CORZ

SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
CWC
Carolinas Wealth Consulting Charlotte, North Carolina $465M AUM 8.53% 1-Year Est. Return
BWP
BSW Wealth Partners Boulder, Colorado $899M AUM 28.56% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Lindbrook Capital's CORZ Position: Q1 2023 in Review

Lindbrook Capital sold out of Core Scientific, Inc. Common Stock (CORZ) in Q1 2023, closing a stake of 182,369 shares — an estimated $13.7K sold.

Lindbrook Capital first reported a position in CORZ in Q4 2022 and held it in 1 quarter. The position peaked at $13.7K in Q4 2022. 10 funds tracked by Wall St. Rank hold CORZ as of Q1 2023.

  • Lindbrook Capital reported no remaining Core Scientific, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Lindbrook Capital sold 182,369 Core Scientific, Inc. Common Stock shares in Q1 2023, an estimated $13.7K.
  • Lindbrook Capital first reported a position in Core Scientific, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Lindbrook Capital's Core Scientific, Inc. Common Stock position peaked at $13.7K in Q4 2022.
  • 10 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q1 2023.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.